2020
DOI: 10.21203/rs.3.rs-52343/v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Development a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19

Abstract: Background: The coronavirus disease 2019 (COVID-19) has brought a global disaster. Quantitative lesions may provide the radiological evidence of the severity of pneumonia and further to assess the effect of comorbidity on patients with COVID-19.Methods: 294 patients with COVID-19 were enrolled from February, 24, 2020 to June, 1, 2020 from six centers. Multi-task Unet network was used to segment the whole lung and lesions from chest CT images. This deep learning method was pre-trained in 650 CT images (550 in p… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 16 publications
(23 reference statements)
0
2
0
Order By: Relevance
“…This drawback has spurred a recent trend in the field of exploring semi-supervised and self-supervised approaches that try to also learn from uncertainty measures and sources other than manual annotations, attempting to reduce the impact of low-quality annotations [230][231][232][233][234][235][236][237]. Finally, some deep learning medical research and decision support methods have been tested and implemented recently in a real-world context [238][239][240][241], with promising results for the future clinical use of deep learning methods.…”
Section: Deep Learningmentioning
confidence: 99%
See 1 more Smart Citation
“…This drawback has spurred a recent trend in the field of exploring semi-supervised and self-supervised approaches that try to also learn from uncertainty measures and sources other than manual annotations, attempting to reduce the impact of low-quality annotations [230][231][232][233][234][235][236][237]. Finally, some deep learning medical research and decision support methods have been tested and implemented recently in a real-world context [238][239][240][241], with promising results for the future clinical use of deep learning methods.…”
Section: Deep Learningmentioning
confidence: 99%
“…Therefore, there is no general automated method for lung assessment and segmentation prepared to deal with all common types of lung findings, for example for use in a clinical setting. We are happy to see a recent effort to deploy deep learning-based methods for COVID-19 classification and segmentation in real hospitals and its use in medical research, with promising results [238][239][240][241], but surveys state that deep learning-based methods are not ready for clinical use [7,8].…”
Section: Gapsmentioning
confidence: 99%